China Universal Asset Management »

Mirum Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $159k 5.4k 29.48
2023-09-30 $31k 986 31.44
2023-06-30 $13k 498 26.10
2023-03-31 $12k 499 24.05
2022-12-31 $7.0k 374 18.72
2022-09-30 $7.0k 345 20.29

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Vertex Pharmaceuticals Common Stock (VRTX)
Adobe Common Stock (ADBE)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Servicenow Common Stock (NOW)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
Visa Inc-class A Shares Common Stock (V)
Workday Inc-class A Common Stock (WDAY)
Alphabet Inc-cl A Common Stock (GOOGL)
Salesforce Common Stock (CRM)

View all positions for China Universal Asset Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals